We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Application to Change Lipitor Patent Accepted by Patent Office
Application to Change Lipitor Patent Accepted by Patent Office
January 20, 2009
An obstacle has been cleared for Pfizer’s best-selling cholesterol drug Lipitor because the U.S. Patent and Trademark Office has accepted the company’s application to correct a technical defect in one of the patents for the drug.